1. Home
  2. Blog
  3. UPSC

DRESS Syndrome

Why is it in the news?

  • The Indian Pharmacopoeia Commission (IPC) issues a drug safety alert regarding the painkiller Meftal. Concerns raised about potential adverse reactions, particularly about the risk of DRESS syndrome.

About DRESS Syndrome

  • DRESS stands for Drug Rash with Eosinophilia and Systemic Symptoms.
  • It is an idiosyncratic reaction to certain drugs like abacavir, allopurinol, and lamotrigine.
Idiosyncratic drug reaction: Unpredictable reactions occurring in a small percentage of patients receiving the drug.
  • Delayed onset of symptoms; Includes fever, skin rash, lymphadenopathy (swelling of lymph nodes), eosinophilia (increase in a type of white blood cells), and various systemic manifestations.
  • Characterized by severe symptoms, with an estimated mortality rate of 10 percent.


About Meftal

  • Meftal is an over-the-counter medication used for pain and inflammation management.
  • Contains mefenamic acid, a member of the nonsteroidal anti-inflammatory drugs (NSAIDs) class.
  • Prescribed for various conditions such as rheumatoid arthritis, menstrual pain, dental pain, inflammation, and fever.


NSAIDs Class

路聽聽聽聽聽聽 Belongs to the class of nonsteroidal anti-inflammatory drugs.

路聽聽聽聽聽聽 Other commonly used NSAIDs include ibuprofen, naproxen, and aspirin.


About Indian Pharmacopoeia Commission (IPC)

  • A body operating independently within the Ministry of Health and Family Welfare.
  • Established to set and update drug standards in India.
  • Basic function involves regular updates of drug standards, aligning with prevalent diseases.
  • Publishes official documents (IP) to enhance the quality of medicines through new additions and updates to existing monographs.
  • Contributes to rational use of generic medicines by publishing the National Formulary of India.
  • Provides IP Reference Substances (IPRS) as fingerprints for identification and purity testing of articles under the Indian Pharmacopoeia.

Benefits of International recognition of the Indian pharmacopeia Standards

Boost Export Opportunities:

  • International recognition of Indian Pharmacopeia Standards eliminates double regulation, duplication in testing, and post-importation checks.
  • Boosts export potential for Indian pharmaceutical products.
  • Provides Indian drug exporters with a competitive edge in global markets.

Affordable Access to Quality Products:

  • Enhances affordability as quality pharmaceuticals from India become more accessible in the global market.

Facilitates Generic Medicine Development:

  • International recognition opens avenues for manufacturers in importing countries to engage in the development of generic medicines.
  • Encourages collaboration and contribution to global healthcare solutions.

Get free UPSC Updates straight to your inbox!

Get Updates on New Notification about APPSC, TSPSC and UPSC

Get Current Affairs Updates Directly into your Inbox

Discover more from AMIGOS IAS

Subscribe now to keep reading and get access to the full archive.

Continue reading